This site is intended for healthcare professionals
Latest industry news
  • Home
  • /
  • News
  • /
  • 2022
  • /
  • 11
  • /
  • Nordic Nanovector to merge with APIM Therapeutics

Nordic Nanovector to merge with APIM Therapeutics

Read time: 1 mins
Published:30th Nov 2022

Nordic Nanovector ASA and all shareholders of APIM Therapeutics ("APIM"), a privately held, clinical-stage cancer-focused biotechnology company, announce that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction

Subject to completion of the Agreement, Nordic Nanovector will purchase shares in APIM, and become the parent entity of APIM. The Agreement follows the review that Nordic Nanovector conducted, in conjunction with Carnegie Investment Bank, to optimise shareholder value following its decision to discontinue the PARADIGME study for Nordic Nanovector's lead asset Betalutin.

Type: industry

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.